FederalDC
Aug 14, 2026
Closes
Oct 1, 2026
TECHNOLOGY LICENSING OPPORTUNITY: Multidimensional Mass Fingerprinting for Antibiotic-Resistant Bacteria (MultiScan-AR)
Special Notice from Triad (LANL) offering a technology licensing opportunity for MultiScan-AR, a multidimensional mass fingerprinting method that identifies pathogens and their antibiotic-resistance profiles rapidly using mass spectrometry. The notice describes the technology, potential market applications (clinical diagnostics, point-of-care, public health, field-deployable medicine), and contact points for licensing at LANL. Responses are due Oct 1, 2026 and the notice remains active through Aug 15, 2027.